Tramadol dependence and withdrawal syndrome: A Case report
Indian Journal of Forensic Medicine & Toxicology · 23.04.2026 · 20 (2) · 8-10
DOI: 10.37506/vhs8dv37 ↗Kurz gefasst
Fallbericht in der Zeitschrift Indian Journal of Forensic Medicine & Toxicology, online erschienen am 23.04.2026. Verfasst von Arun Ashokan und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Tramadol is a synthetic analgesic that appears to have two mechanisms of action: a reuptake inhibition of serotonin and noradrenaline and a weak μ-opioid receptor agonism. Even though its potential for abuse is well reported, the drug is readily available off on the market and is not regarded as a controlled substance in many nations, in contrast to the majority of other opioids. The patient in this case report developed severe tramadol dependence after taking large doses of the drug to treat his musculoskeletal pain. We suggest that It should be made a controlled substance at the administrative levels due to the possibility of dependence and severe withdrawal symptoms.
Zitieren
APA
Ashokan, A., & Sreekanth, C. (2026). Tramadol dependence and withdrawal syndrome: A Case report. Indian Journal of Forensic Medicine & Toxicology, 20(2), 8-10. https://doi.org/10.37506/vhs8dv37
Vancouver
Ashokan A, Sreekanth C. Tramadol dependence and withdrawal syndrome: A Case report. Indian Journal of Forensic Medicine & Toxicology. 2026;20(2):8-10. doi:10.37506/vhs8dv37
BibTeX
@article{Ashokan2026,
author = {Ashokan, Arun and Sreekanth, C},
title = {Tramadol dependence and withdrawal syndrome: A Case report},
journal = {Indian Journal of Forensic Medicine & Toxicology},
year = {2026},
volume = {20},
number = {2},
pages = {8--10},
doi = {10.37506/vhs8dv37}
}
EUVIMED